Tidepool said this week that it raised $6 million from JDRF and the Leona M. & Harry B. Helmsley Charitable Trust to support the development of Tidepool Loop – a hybrid, closed-loop automated insulin delivery app.
Tidepool, a non-profit diabetes data management group, is working to create an FDA-regulated app that is compatible with multiple insulin pumps and continuous glucose monitors.
“Loop is one of the greatest things out there right now,” David Panzirer, trustee of The Helmsley Charitable Trust, said in prepared remarks. “My daughter has been on [DIY] Loop for nearly two years. There have definitely been improvements in her clinical care, but the real story is the improvement in her quality of life. My daughter tells me that she doesn’t need to think about her diabetes as much as she used to.”
“This is exactly what we dreamed of when we launched the JDRF Open Protocol Initiative in 2017 – to accelerate innovation, give users greater control over insulin delivery devices, and expand their ability to choose system components that work best for them,” Dr. Aaron Kowalski, chief mission officer for JDRF, added. “Through the Tidepool Loop project, Tidepool will demonstrate the power and value of an interoperable ecosystem of diabetes devices, giving people with diabetes more options for better control with less burden.”
“Tidepool’s mission has always been to build and deliver ground-breaking software that helps people living with diabetes,” Tidepool’s founder & CEO, Howard Look, said. “With Tidepool Loop, we are building upon the incredible efforts and innovation of the #WeAreNotWaiting movement, including the work of Nate Racklyeft, Pete Schwamb, Ben West, and Katie DiSimone. By taking on Tidepool Loop, we will bring Loop to an even a broader community, make it work with commercial, in-warranty devices, and deliver it through FDA pathways.”
In October, Tidepool announced that Insulet‘s (NSDQ:PODD) Omnipod Dash device will be the first insulin pump to use the Tidepool Loop app.
Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.
This is great news for all people who have problems with blood sugar levels. I think that such applications can help people not to forget to take medication, and the treatment itself will be more effective. I hope that this project will have more investors:)
Thank you for sharing with me!